Workflow
JIEQIANG EQUIPMENT(300875)
icon
Search documents
捷强装备(300875) - 2024年度独立董事述职报告(易宏)
2025-04-28 18:13
2024年度独立董事述职报告 (易宏) 二零二五年四月 天津捷强动力装备股份有限公司 2024年度独立董事述职报告(易宏) 各位股东及股东代表: 二、独立董事年度履职概况 (一)2024年度出席董事会、股东会情况 2024年度,公司共召开8次董事会,审议通过了40项议案,本人应出席8次,实际 以现场或通讯方式亲自出席8次,对提案涉及的事项进行了客观地分析、研究,通过 2 本人作为天津捷强动力装备股份有限公司(以下简称"公司")第三届、第四届 董事会独立董事,在2024年任职期间,严格遵守《公司法》《证券法》《上市公司独 立董事管理办法》《深圳证券交易所创业板股票上市规则》《深圳证券交易所上市公 司自律监管指引第2号——创业板上市公司规范运作》等有关法律法规和《公司章 程》《独立董事工作制度》的规定和要求,在工作中独立、勤勉、尽责地履行独立董 事职责和义务,注重与公司董事会其他董事、监事、经理层的密切沟通,积极参与董 事会决策,必要时发表独立意见,及时全面深入了解公司运营情况和会议决议执行情 况,维护公司整体利益和全体股东尤其是中小股东合法权益。 现将本人2024年度履行独立董事职责情况报告如下: 一、独立董事 ...
捷强装备(300875) - 《内幕信息知情人登记备案制度》(2025年4月修订)
2025-04-28 18:13
天津捷强动力装备股份有限公司 内幕信息知情人登记备案制度 (2025 年 4 月修订) 第一章 总 则 第一条 为进一步规范天津捷强动力装备股份有限公司(以下简称"公司") 的内幕信息管理行为,加强内幕信息保密工作,以维护信息披露的公平原则,根据 《中华人民共和国公司法》(以下简称"《公司法》")、《中华人民共和国证券 法》(以下简称"《证券法》")、《深圳证券交易所创业板股票上市规则》、 《上市公司信息披露管理办法》、《上市公司监管指引第 5 号——上市公司内幕信 息知情人登记管理制度》等有关法律、法规、规章和《天津捷强动力装备股份有限 公司章程》(以下简称"《公司章程》")、《信息披露管理办法》的有关规定, 制定本制度。 第二条 董事会是公司内幕信息的管理机构,保证内幕信息知情人档案真实、 准确和完善,董事长为主要负责人。董事会秘书负责办理公司内幕信息知情人的登 记入档事宜。公司审计委员会对本制度实施情况进行监督。 第三条 证券与投资部是公司唯一的信息披露机构。未经董事会批准同意,公 司任何部门和个人不得向外界泄露、报道、传送涉及公司内幕信息和信息披露的 内容。对外报道、传送的文件、录音(像)带、光盘等涉 ...
捷强装备(300875) - 《董事会审计委员会实施细则》(2025年4月修订)
2025-04-28 18:13
天津捷强动力装备股份有限公司 董事会审计委员会实施细则 (2025 年 4 月修订) 第一章 总 则 第一条 为强化董事会决策功能,持续完善公司内控体系建设,确保董事 会对经理层的有效监督管理,不断完善公司治理结构,根据《中华人民共和国公 司法》、《天津捷强动力装备股份有限公司章程》(以下简称"《公司章程》")、 《上市公司治理准则》、《深圳证券交易所上市公司自律监管指引第 2 号—— 创业板上市公司规范运作》及其他有关规定,公司特设立董事会审计委员会, 并制定本实施细则。 第二条 董事会审计委员会是董事会设立的专门工作机构,主要负责公司 与外部审计的沟通及对其的监督核查、对内部审计的监管、公司内部控制体系 的评价与完善,以及对公司正在运作的重大投资项目等进行风险分析。 第二章 人员组成 第三条 审计委员会成员由三名不担任高级管理人员的董事组成,独立董 事占多数,审计委员会的召集人应当为专业会计人士。 审计委员会成员应当勤勉尽责,切实有效地监督、评估公司内外部审计工 作,促进公司建立有效的内部控制并提供真实、准确、完整的财务报告。 第五条 审计委员会设召集人一名,由作为会计专业人士的独立董事担任, 负责主持委 ...
捷强装备(300875) - 关于增加经营范围、制定管理制度并修订《公司章程》和部分管理制度的公告
2025-04-28 18:13
证券代码:300875 证券简称: 捷强装备 公告编号:2025-014 天津捷强动力装备股份有限公司 关于增加经营范围、制定管理制度并修订《公司章程》和部分 管理制度的公告 本公司及董事会全体成员保证公告内容真实、准确和完整,没有虚假 记载、误导性陈述或重大遗漏。 根据《公司法》《证券法》《上市公司章程指引(2025 年修订)》《上市 公司股东会规则》《深圳证券交易所创业板股票上市规则》以及《深圳证券交 易所上市公司自律监管指引第 2 号——创业板上市公司规范运作》等有关法律、 法规、规范性文件的最新规定,并结合公司的实际情况,天津捷强动力装备股 份有限公司(以下简称"公司")于 2025 年 4 月 27 日召开了第四届董事会第 四次会议,审议通过了《关于制定及修订公司部分管理制度的议案》《关于增 加经营范围并修订<公司章程>的议案》,具体如下: 一、拟增加经营范围情况 为更好满足公司业务发展需求,公司计划在原有经营范围的基础上,拟 增加经营范围"消毒产品或者器械的生产、销售;超氧化钾等危险化学品销 售"。 | 修订条款 | 原《公司章程》条款内容 | 修订后《公司章程》条款及内容 | | --- | - ...
捷强装备(300875) - 2024年度独立董事述职报告(何锦成)
2025-04-28 18:13
二零二五年四月 天津捷强动力装备股份有限公司 2024年度独立董事述职报告 (何锦成) 本人何锦成,男,汉族,1964年2月出生,中国国籍,无境外永久居留权,数理 统计专业,本科学历,中国注册资产评估师、中国注册会计师、高级会计师和一级建 造师。现任浙江正大会计师事务所有限公司高级会计师、合伙人。2024年7月至今, 担任公司独立董事。 (二)独立性说明 2024年度独立董事述职报告(何锦成) 各位股东及股东代表: 本人作为天津捷强动力装备股份有限公司(以下简称"公司")第四届董事会独 立董事,在2024年任职期间,严格遵守《公司法》《证券法》《上市公司独立董事管 理办法》《深圳证券交易所创业板股票上市规则》《深圳证券交易所上市公司自律监 管指引第2号——创业板上市公司规范运作》等有关法律法规和《公司章程》《独立董 事工作制度》的规定和要求,在工作中独立、勤勉、尽责地履行独立董事职责和义 务,注重与公司董事会其他董事、监事、经理层的密切沟通,积极参与董事会决策, 必要时发表独立意见,及时全面深入了解公司运营情况和会议决议执行情况,维护公 司整体利益和全体股东尤其是中小股东合法权益。 现将本人2024年度履行独 ...
捷强装备(300875) - 2025 Q1 - 季度财报
2025-04-28 17:55
Financial Performance - The company's operating revenue for Q1 2025 was ¥32,922,489.04, representing a 54.03% increase compared to ¥21,374,416.83 in the same period last year[5]. - The net loss attributable to shareholders was ¥5,180,022.90, a 8.40% improvement from a loss of ¥5,655,354.43 in the previous year[5]. - The company's net loss for the current period was ¥132,405,985.29, compared to a loss of ¥127,225,962.39 in the previous period, indicating a slight increase in losses[21]. - The net profit for the current period is -4,449,759.57, compared to -7,882,599.77 in the previous period, indicating an improvement of approximately 43.5%[24]. - The total comprehensive income for the current period is -4,449,759.57, while the previous period was -7,882,599.77, reflecting a reduction in losses[24]. - Basic and diluted earnings per share are both -0.05, compared to -0.06 in the previous period, showing a slight improvement[24]. Cash Flow and Liquidity - The net cash flow from operating activities was -¥52,391,132.71, a significant decline of 253.43% compared to -¥14,823,624.97 in the prior year[5]. - Cash flow from operating activities shows a net outflow of -52,391,132.71, worsening from -14,823,624.97 in the previous period[25]. - The company's cash and cash equivalents decreased to ¥97,339,487.03 from ¥217,819,411.25, a decline of approximately 55.4%[19]. - The ending cash and cash equivalents balance is 82,903,648.25, down from 137,183,885.09 in the previous period, reflecting a decrease in liquidity[26]. - Cash inflow from investment activities is 171,887,304.83, significantly higher than 4,235,109.58 in the previous period[25]. - Cash outflow from investment activities is 248,106,841.00, compared to 231,614,771.30 in the previous period, indicating increased investment spending[26]. - Cash flow from financing activities shows a net inflow of 9,566,389.71, compared to a net outflow of -6,368,708.33 in the previous period, indicating improved financing conditions[26]. Assets and Liabilities - Total assets at the end of the reporting period were ¥1,367,288,202.86, an increase of 4.53% from ¥1,308,019,534.65 at the end of the previous year[5]. - Current liabilities increased to ¥323,934,996.54 from ¥262,011,703.95, representing a rise of approximately 23.6%[20]. - The total equity attributable to shareholders decreased slightly by 0.46% to ¥961,029,013.44 from ¥965,472,328.23 at the end of the previous year[5]. Shareholder Information - The total number of common shareholders at the end of the reporting period is 16,487[14]. - The largest shareholder, Pan Feng, holds 25.41% of the shares, totaling 25,369,500 shares[14]. - The top ten shareholders hold a significant portion of shares, with the top three shareholders collectively owning 42.58%[14]. - The company has a total of 39,564,711 restricted shares, with 27,521,629 shares released during the period[15]. Share Repurchase and Investment - The company plans to repurchase shares with a total amount between RMB 15 million and RMB 30 million, with a maximum price of RMB 41.82 per share[17]. - The estimated number of shares to be repurchased is between 358,700 and 717,300, representing 0.36% to 0.72% of the total share capital[17]. - The company has completed the repurchase of 704,700 shares, accounting for 0.71% of the total share capital, with a total transaction amount of RMB 16,873,951.40[17]. - The highest transaction price during the buyback was RMB 29.90 per share, while the lowest was RMB 17.52 per share[17]. - The company has implemented a share buyback plan to support employee stock ownership and equity incentives[17]. Research and Development - Research and development expenses decreased by 42.34% to ¥4,216,858.97 from ¥7,313,581.37 in the previous year[11]. - Research and development expenses decreased to ¥4,216,858.97 from ¥7,313,581.37, a reduction of approximately 42.8%[22]. Investment Income - The company reported an investment income of ¥1,310,334.75, a substantial increase of 1,106.56% compared to ¥108,600.82 in the same period last year[11]. - The company reported an investment income of ¥1,310,334.75, compared to ¥108,600.82 in the previous period, reflecting a substantial increase[22]. Operational Performance - Total revenue for the current period reached ¥32,922,489.04, a significant increase from ¥21,374,416.83 in the previous period, representing a growth of approximately 54.5%[22]. - Total operating costs amounted to ¥41,255,609.21, compared to ¥39,361,833.80 in the previous period, indicating an increase of about 4.8%[22]. - The company reported a significant increase in cash received from sales, totaling 76,266,269.45, compared to 70,400,545.49 in the previous period, indicating growth in revenue generation[25]. Audit and Investor Confidence - The company has not undergone an audit for the first quarter report, which may affect investor confidence[27].
2025年天津市新质生产力发展研判:把发展新质生产力作为推动高质量发展的重要着力点[图]
Chan Ye Xin Xi Wang· 2025-04-14 01:19
内容概要:近年来,天津市围绕深入实施高质量发展"十项行动",推进科技创新、产业焕新、城市更 新,有效盘活存量、培育增量、提升质量,不断健全机制、创新方法,着力提升改革的精准性、针对 性、实效性,以更大的决心和力度不断推动改革工作取得新成效。在政府部门大力推动下,天津在新质 生产力方面稳步发展,"三新""三量"取得了明显成效,绿色石化、高端装备、汽车制造等产业核心竞争 力不断提升,为经济高质量发展注入了新的动力和活力。 上市企业:渤海化学(600800)、海油工程(600583)、中海油服(601808)、长荣股份(300195)、 建科智能(300823)、捷强装备(300875)、美腾科技(688420)、凯发电气(300407) 相关企业:中国石油化工股份有限公司天津分公司、中海石油(中国)有限公司天津分公司、中国石油 天然气股份有限公司大港油田分公司、天津渤海化工集团有限责任公司、天津得川石化有限公司、中沙 (天津)石化有限公司、中石化(天津)石油化工有限公司、彼合彼方机器人(天津)有限公司、天津 超众机器人科技有限公司、艾普斯(天津)工业组装技术有限公司、天津朗誉机器人有限公司、伽利略 (天津)技术有 ...
中国核工业机器人行业决策建议及竞争战略分析报告2025~2031年
Sou Hu Cai Jing· 2025-04-07 06:49
Overview - The report provides a comprehensive analysis of the nuclear industrial robotics industry in China, including its definition, characteristics, classification, regulatory environment, and industry chain structure [1][3][4]. Current Status - The global nuclear industrial robotics industry has a significant development history and current market size, with various typical products from countries like the USA, Russia, and France [2][4][5]. - The report highlights the technological advancements and international certifications within the nuclear industrial robotics sector, including patent applications and popular technologies [2][4][6]. - China's nuclear industrial robotics market has seen growth in import and export trade, with detailed statistics on trade volumes and values from 2019 to 2024 [3][4][6]. Market Dynamics - The competitive landscape of the Chinese nuclear industrial robotics industry is analyzed, including the types of market players, their entry strategies, and the current state of research and development investments [3][6][7]. - The report discusses the supply chain dynamics, cost structures, and profitability levels of nuclear industrial robots, along with procurement models and core component localization [4][6][7]. Product Segmentation - The report examines various segments of the nuclear industrial robotics market, such as nuclear detection and maintenance robots, on-site operation robots, emergency response robots, and decommissioning robots, detailing their current status and future trends [5][6][8]. Policy and Future Outlook - The policy environment affecting the nuclear industrial robotics industry in China is explored, including standards, national policies, and their implications for industry development [8][12]. - Future growth points and market trends for the nuclear industrial robotics industry in China are forecasted, emphasizing investment opportunities and strategic recommendations for stakeholders [9][10][12].
捷强装备: 2024年度业绩预告修正公告
Zheng Quan Zhi Xing· 2025-04-03 11:35
Performance Forecast - The company expects a loss of RMB 145 million to RMB 180 million for the reporting period, compared to a loss of RMB 67.90 million in the same period last year [1] - The revised forecast indicates a loss of RMB 260 million for the reporting period, which is a significant increase from the previous estimate [1] - The net profit attributable to shareholders is expected to decline by 113.54% to 165.08% compared to the same period last year [1] Reasons for Performance Change - The anticipated performance decline is attributed to adjustments in sales contract prices by the client's superior department, necessitating the return of part of the product price difference [1] - The company has revised its performance forecast to ensure an objective, fair, and truthful reflection of its financial status and operating results for 2024 [1] Communication with Auditors - The financial data related to the performance forecast has not been audited by registered accountants, but there has been communication with the auditing firm regarding the revision, with no significant disagreements reported [1]
捷强装备(300875) - 2024 Q4 - 年度业绩预告
2025-04-03 10:50
Financial Performance Expectations - The company expects a net loss of approximately RMB 145 million to RMB 180 million for the fiscal year 2024, representing a decline of 113.54% to 165.08% compared to the previous year's loss of RMB 67.90 million[2]. - The net loss after deducting non-recurring gains and losses is projected to be between RMB 160 million and RMB 197 million, a decrease of 42.89% to 75.94% from last year's loss of RMB 111.97 million[2]. Impairment Projections - The company anticipates goodwill impairment of approximately RMB 70 million to RMB 85 million due to systematic testing, along with fixed asset impairment estimated at RMB 10 million to RMB 15 million[5]. - Inventory impairment is expected to amount to RMB 15 million to RMB 25 million, impacting the company's net profit[5]. Non-Recurring Gains and Losses - Non-recurring gains and losses are projected to affect net profit by approximately RMB 15 million to RMB 17 million in 2024[5]. Financial Reporting and Disclosure - The financial data presented in the earnings forecast is preliminary and has not been audited by an external auditor[6]. - The detailed financial data will be disclosed in the company's 2024 annual report, urging investors to make cautious decisions[6].